一个随机对照试验比较抗抑郁药单一治疗的有效性和安全性
N Simple Santi1, Sashi B Biswal1, Birendra Narayan Naik2
1Pharmacology, Veer Surendra Sai Institute of Medical Sciences and Research, Burla, IND.
Cureus
|May 27, 2024
概括
与埃斯基塔洛普拉姆和维拉佐相比,西在抑郁症症状上显著改善,副作用较少. 这项研究强调了西作为重大抑郁症 (MDD) 的有希望的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 主流抗抑郁药通常无法完全缓解主要抑郁症 (MDD) 的症状,并且可能产生显著的副作用.
- 研究血清素 (5-HT) 神经传递的作用对于理解抑郁症病因和开发有效治疗方法至关重要.
- 目前抗抑郁药的局限性需要探索MDD的新疗法.
研究的目的:
- 为了比较vortioxetine,vilazodone和escitalopram在治疗主要抑郁症 (MDD) 的疗效和安全性.
- 评估这些抗抑郁药对汉密尔顿抑郁评分表 (HDRS) 和蒙哥马利奥斯伯格抑郁评分表 (MADRS) 评分的影响.
- 评估与每个抗抑郁药物相关的不良事件的发生率和严重程度.
主要方法:
- 一项开放的,随机的,三臂研究,涉及96名被诊断患有MDD的患者.
- 参与者接受了维拉佐 (每天20-40毫克),伏尔西丁 (每天5-20毫克) 或埃斯基塔洛普拉姆 (每天10-20毫克) 的单一治疗,持续了16周.
- 使用HDRS和MADRS得分评估有效性,通过不良事件监测评估安全性.
主要成果:
- 这三种抗抑郁药在16周后从基线显著降低了HDRS和MADRS得分.
- 与埃斯基塔洛普拉姆和维拉佐相比,西在HDRS和MADRS得分上显示出了统计学上显著的较大降低.
- 报告了不良事件,恶心和吐是最常见的;然而,大多数不是严重的,只有五名参与者因副作用而退出.
结论:
- 与埃斯基塔洛普拉姆和维拉佐相比,西在降低抑郁症症状严重程度方面表现出更高的疗效.
- 伏尔托克塞丁与更有利的副作用概况有关,包括更少和更轻微的不良事件.
- 建议对更大,更多样化的群体进行进一步的研究,以证实这些发现,并探索伏西的抗抑郁药潜力.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
01:30Electroconvulsive Therapy
36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
370
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
370
01:12Hazard Ratio
114
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
114
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
01:25Antidepressant Drugs: Overview
450
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
450